| Literature DB >> 24753537 |
Alexa Triot1, Päivi M Järvinen1, Juan I Arostegui2, Dhaarini Murugan1, Naschla Kohistani1, José Luis Dapena Díaz3, Tomas Racek1, Jacek Puchałka1, E Michael Gertz4, Alejandro A Schäffer4, Daniel Kotlarz1, Dietmar Pfeifer5, Cristina Díaz de Heredia Rubio3, Mehmet Akif Ozdemir6, Turkan Patiroglu6, Musa Karakukcu6, José Sánchez de Toledo Codina3, Jordi Yagüe2, Ivo P Touw7, Ekrem Unal6, Christoph Klein1.
Abstract
Severe congenital neutropenia (SCN) is characterized by low numbers of peripheral neutrophil granulocytes and a predisposition to life-threatening bacterial infections. We describe a novel genetic SCN type in 2 unrelated families associated with recessively inherited loss-of-function mutations in CSF3R, encoding the granulocyte colony-stimulating factor (G-CSF) receptor. Family A, with 3 affected children, carried a homozygous missense mutation (NM_000760.3:c.922C>T, NP_000751.1:p.Arg308Cys), which resulted in perturbed N-glycosylation and aberrant localization to the cell surface. Family B, with 1 affected infant, carried compound heterozygous deletions provoking frameshifts and premature stop codons (NM_000760.3:c.948_963del, NP_000751.1:p.Gly316fsTer322 and NM_000760.3:c.1245del, NP_000751.1:p.Gly415fsTer432). Despite peripheral SCN, all patients had morphologic evidence of full myeloid cell maturation in bone marrow. None of the patients responded to treatment with recombinant human G-CSF. Our study highlights the genetic and morphologic SCN variability and provides evidence both for functional importance and redundancy of G-CSF receptor-mediated signaling in human granulopoiesis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24753537 PMCID: PMC4055927 DOI: 10.1182/blood-2013-11-535419
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113